Browsing by Subject "mesenchymal stem cells"
Now showing items 1-9 of 9
-
(2018-04-30)In human and veterinary medicine, mesenchymal stem cells (MSCs) have significant therapeutic benefits. MSCs can differentiate into a variety of cells including osteoblasts, chondrocytes, or adipocytes. Fetal bovine serum ...
-
(2017-06-09)Aging affects the reproductive efficiency of females. In rodent models, injection of mesenchymal stem cells (MSCs) improves function and induces trophic mRNA expression in ovaries compromised by chemotherapy. However, ...
-
(2020-07-13)Engineered bone graft designs have been largely inspired by adult bone despite significant deviation from the composition of anabolic bone. Highly osteogenic extracellular matrix (ECM) secreted by human mesenchymal stem ...
-
(2011-08-08)Mesenchymal stem cells are more and more widely used in tissue engineering due to their pluripotency and no relative ethical problems. Traditional characterization techniques to detect mesenchymal stem cell states include ...
-
(2015-05-01)Mesenchymal stem cells (MSCs), are plastic adherent cells that are readily isolated from various sources, possess stem-cell-like properties and show unique beneficial features in in vivo models of diseases. In present ...
-
(2017-05-05)Osteochondrosis and traumatic osteochondral defects are debilitating disorders affecting articular cartilage of millions of human and veterinary species. As articular cartilage is highly specialized and lacks reparative ...
-
(2022-11-20)Human mesenchymal stem cells (hMSCs) are a promising therapeutic owing to their ability to differentiate into osteogenic, chondrogenic, and adipogenic tissue as well as their immunomodulatory characteristics. These cells, ...
-
(2015-11-10)Mesenchymal stem cells (MSCs) are undifferentiated cells that are being investigated as a therapy for equine musculoskeletal disease. Fetal bovine serum (FBS) is commonly used as a serum supplement when culturing MSCs. ...
-
(2023-01-18)Osteosarcoma (OS) is the most common bone tumor in the pediatric population, representing >50% of bone malignancies in patients <20 years old. Following surgical resection of the tumor, allografts or metal endoprostheses ...